Hiroji Oida

2.5k total citations
19 papers, 2.1k citations indexed

About

Hiroji Oida is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Hiroji Oida has authored 19 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Hiroji Oida's work include Inflammatory mediators and NSAID effects (10 papers), Receptor Mechanisms and Signaling (4 papers) and Bone health and treatments (3 papers). Hiroji Oida is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Receptor Mechanisms and Signaling (4 papers) and Bone health and treatments (3 papers). Hiroji Oida collaborates with scholars based in Japan, United Kingdom and Russia. Hiroji Oida's co-authors include Shuh Narumiya, Yukihiko Sugimoto, Fumitaka Ushikubi, Atsushi Ichikawa, Masahiko Negishi, Eri Segi‐Nishida, Yoshiya Aze, A. Yamasaki, Tatsunori Murata and Takashi Tanaka and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Hiroji Oida

18 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroji Oida Japan	14	989	654	403	399	349	19	2.1k
Margot C. LaPointe United States	31	389 0.4×	1.0k 1.5×	168 0.4×	191 0.5×	341 1.0×	48	2.2k
Barrie Ashby United States	25	350 0.4×	819 1.3×	117 0.3×	186 0.5×	252 0.7×	47	1.9k
Kenneth P. Chepenik United States	12	230 0.2×	917 1.4×	118 0.3×	252 0.6×	427 1.2×	36	1.9k
Scott A. Myers United States	12	444 0.4×	443 0.7×	132 0.3×	169 0.4×	182 0.5×	18	1.3k
John Rediske United States	17	531 0.5×	490 0.7×	108 0.3×	80 0.2×	467 1.3×	28	1.9k
Richard J. Focht United States	10	471 0.5×	472 0.7×	193 0.5×	385 1.0×	73 0.2×	10	1.4k
G W Dorn United States	24	236 0.2×	1.7k 2.6×	152 0.4×	296 0.7×	385 1.1×	46	2.6k
Michael S. Simonson United States	33	161 0.2×	1.2k 1.8×	190 0.5×	174 0.4×	1.0k 2.9×	72	2.8k
Mu-En Lee United States	23	132 0.1×	1.7k 2.7×	168 0.4×	305 0.8×	283 0.8×	24	2.7k
Vincent Sauzeau France	27	230 0.2×	1.8k 2.8×	98 0.2×	175 0.4×	721 2.1×	51	3.3k

Countries citing papers authored by Hiroji Oida

Since Specialization

Citations

This map shows the geographic impact of Hiroji Oida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroji Oida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroji Oida more than expected).

Fields of papers citing papers by Hiroji Oida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroji Oida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroji Oida. The network helps show where Hiroji Oida may publish in the future.

Co-authorship network of co-authors of Hiroji Oida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroji Oida. A scholar is included among the top collaborators of Hiroji Oida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroji Oida. Hiroji Oida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Sekine, Shuichi, et al.. (2013). The role of cyclophilin D in interspecies differences in susceptibility to hepatotoxic drug-induced mitochondrial injury. Biochemical Pharmacology. 86(10). 1507–1514. 4 indexed citations

2.

Maruyama, Toru, Yoshihiko Nakai, Hiroji Oida, et al.. (2012). Synthesis and evaluation of γ-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists. Bioorganic & Medicinal Chemistry. 20(11). 3502–3522. 8 indexed citations

3.

Maruyama, Toru, Yoshihiko Nakai, Hideyuki Yoshida, et al.. (2012). Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists. Bioorganic & Medicinal Chemistry. 20(7). 2235–2251. 18 indexed citations

4.

Maruyama, Toru, Masayuki Nakano, Yoshihiko Nakai, et al.. (2011). Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity. Bioorganic & Medicinal Chemistry Letters. 22(1). 396–401. 8 indexed citations

5.

Ninomiya, Tadashi, Akihiro Hosoya, Toru Hiraga, et al.. (2010). Prostaglandin E2 receptor EP4-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiation. European Journal of Pharmacology. 650(1). 396–402. 18 indexed citations

6.

Hayashi, Ken, et al.. (2005). Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis. Journal of Bone and Joint Surgery - British Volume. 87-B(8). 1150–1156. 28 indexed citations

7.

Kobayashi, Takuya, Mayumi Matsumoto, Hideto Sano, et al.. (2004). Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. Journal of Clinical Investigation. 114(6). 784–794. 72 indexed citations

8.

Kobayashi, Takuya, Mayumi Matsumoto, Hideto Sano, et al.. (2004). Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. Journal of Clinical Investigation. 114(6). 784–794. 308 indexed citations

9.

Yoshida, Keiji, Hiroji Oida, Takuya Kobayashi, et al.. (2002). Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proceedings of the National Academy of Sciences. 99(7). 4580–4585. 273 indexed citations

10.

Oida, Hiroji, et al.. (1999). Intratumoral tumor necrosis factor induction and tumor growth suppression by ONO-4007, a low-toxicity lipid A analog.. PubMed. 18(6A). 4283–9. 9 indexed citations

11.

Segi‐Nishida, Eri, Yukihiko Sugimoto, A. Yamasaki, et al.. (1998). Patent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient Mice. Biochemical and Biophysical Research Communications. 246(1). 7–12. 264 indexed citations

12.

Oida, Hiroji, Masakazu Hirata, Yukihiko Sugimoto, et al.. (1997). Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain. FEBS Letters. 417(1). 53–56. 55 indexed citations

13.

Sugimoto, Yukihiko, A. Yamasaki, Eri Segi‐Nishida, et al.. (1997). Failure of Parturition in Mice Lacking the Prostaglandin F Receptor. Science. 277(5326). 681–683. 495 indexed citations

14.

Tone, Yoshinori, Hiroyasu Inoue, Shuntaro Hara, et al.. (1997). The regional distribution and cellular localization of mRNA encoding rat prostacyclin synthase.. PubMed. 72(3). 268–77. 39 indexed citations

15.

Sugimoto, Yukihiko, Masato Katsuyama, Hiroji Oida, et al.. (1997). Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. American Journal of Physiology-Gastrointestinal and Liver Physiology. 272(3). G681–G687. 84 indexed citations

16.

Takebayashi, Hirohide, Hiroji Oida, Kazuhiko Fujisawa, et al.. (1996). Hormone-induced apoptosis by Fas-nuclear receptor fusion proteins: novel biological tools for controlling apoptosis in vivo.. PubMed. 56(18). 4164–70. 17 indexed citations

17.

Oida, Hiroji, Tsunehisa Namba, Yukihiko Sugimoto, et al.. (1995). In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. British Journal of Pharmacology. 116(7). 2828–2837. 186 indexed citations

18.

Oida, Hiroji, et al.. (1995). Distribution and function of the prostanoid receptors. The Japanese Journal of Pharmacology. 67. 74–74.

19.

Namba, Toshiyuki, Hiroji Oida, Yukihiko Sugimoto, et al.. (1994). cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla. Journal of Biological Chemistry. 269(13). 9986–9992. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact